array:24 [
  "pii" => "S1578219015002127"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.07.014"
  "estado" => "S300"
  "fechaPublicacion" => "2015-10-01"
  "aid" => "1170"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2015;106:682-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 772
    "formatos" => array:3 [
      "EPUB" => 50
      "HTML" => 521
      "PDF" => 201
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731015002008"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2015.03.008"
      "estado" => "S300"
      "fechaPublicacion" => "2015-10-01"
      "aid" => "1170"
      "copyright" => "Elsevier España, S.L.U. y AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2015;106:682-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 924
        "formatos" => array:3 [
          "EPUB" => 3
          "HTML" => 503
          "PDF" => 418
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
        "titulo" => "Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "682"
            "paginaFinal" => "683"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Toxic epidermal necrolysis induced by vemurafenib"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figura 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 732
                "Ancho" => 976
                "Tamanyo" => 146372
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">En esta imagen a mayor aumento&#44; se aprecian grandes ampollas superficiales y &#225;reas de necrosis&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; Lapresta, A&#46; Dotor, C&#46; Gonz&#225;lez-Herrada"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Lapresta"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Dotor"
              ]
              2 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Gonz&#225;lez-Herrada"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015002127"
          "doi" => "10.1016/j.adengl.2015.07.014"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002127?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002008?idApp=UINPBA000044"
      "url" => "/00017310/0000010600000008/v1_201510020746/S0001731015002008/v1_201510020746/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219015002048"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.07.006"
    "estado" => "S300"
    "fechaPublicacion" => "2015-10-01"
    "aid" => "1171"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:684-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 676
      "formatos" => array:3 [
        "EPUB" => 50
        "HTML" => 390
        "PDF" => 236
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Erythema Multiforme Contact Dermatitis After Accidental Exposure to Acrylate-based Printing Inks"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "684"
          "paginaFinal" => "685"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eritema multiforme de contacto tras exposici&#243;n accidental a acrilatos en tintas de impresi&#243;n"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 472
              "Ancho" => 1300
              "Tamanyo" => 114379
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B&#44; Similar lesions on both thighs and the trunk &#40;areas not exposed to direct contact with ink&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S&#46; C&#243;rdoba, N&#46; Puente, A&#46; Calder&#243;n, J&#46;M&#46; Borbujo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "C&#243;rdoba"
            ]
            1 => array:2 [
              "nombre" => "N&#46;"
              "apellidos" => "Puente"
            ]
            2 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Calder&#243;n"
            ]
            3 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Borbujo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101500201X"
        "doi" => "10.1016/j.ad.2015.02.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101500201X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002048?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002048/v1_201510011018/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219015002103"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.07.012"
    "estado" => "S300"
    "fechaPublicacion" => "2015-10-01"
    "aid" => "1168"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:680-1"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 746
      "formatos" => array:3 [
        "EPUB" => 44
        "HTML" => 481
        "PDF" => 221
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Tuberous Lesion of the Penis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "680"
          "paginaFinal" => "681"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Lesi&#243;n tuberosa en el pene"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 732
              "Ancho" => 976
              "Tamanyo" => 268580
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Intranuclear human herpes virus 8 &#40;HVV-8&#41; expression &#40;immunohistochemical HHV-8 stain&#44; original magnification &#215;40&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Miguel-G&#243;mez, S&#46; P&#233;rez-Gala, P&#46; Ja&#233;n-Olasolo"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Miguel-G&#243;mez"
            ]
            1 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "P&#233;rez-Gala"
            ]
            2 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Ja&#233;n-Olasolo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731015001982"
        "doi" => "10.1016/j.ad.2015.02.010"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015001982?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002103?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002103/v1_201510011018/en/main.assets"
  ]
  "en" => array:16 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
    "titulo" => "Toxic epidermal necrolysis induced by vemurafenib"
    "tieneTextoCompleto" => true
    "saludo" => "To the Editor&#58;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "682"
        "paginaFinal" => "683"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Lapresta, A&#46; Dotor, C&#46; Gonz&#225;lez-Herrada"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Lapresta"
            "email" => array:1 [
              0 => "amlapresta&#64;gmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Dotor"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Gonz&#225;lez-Herrada"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario de Getafe&#44; Getafe&#44; Madrid&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Anatom&#237;a Patol&#243;gica&#44; Hospital Universitario de Getafe&#44; Getafe&#44; Madrid&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1627
            "Ancho" => 1221
            "Tamanyo" => 697919
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Histology showed extensive&#44; confluent necrosis in the epidermis and subepidermal detachment&#46; In the upper dermis&#44; there was a predominantly perivascular lymphoplasmacytic infiltrate &#40;hematoxylin-eosin&#44; original magnification &#215;2&#46;5&#41;&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We report the case of a 68-year-old man diagnosed with a nodular melanoma &#40;Breslow depth&#44; 11<span class="elsevierStyleHsp" style=""></span>mm&#41; in the right submammary region&#46; He had no relevant past history and reported taking no medication&#44; Radiography showed enlarged bilateral axillary&#44; mediastinal&#44; and hilar lymph nodes and multiple bilateral micronodules in the upper and lower lobes of the lung&#46; These nodules showed high uptake&#44; suggestive of metastatic lesions&#44; on the positron emission tomography&#8211;computed tomography scan&#46; Assessment of the <span class="elsevierStyleItalic">BRAF</span> V600E mutation was positive&#46; With a diagnosis of BRAF-positive stage IV metastatic melanoma&#44; treatment was initiated with vemurafenib 960&#160;mg every 12<span class="elsevierStyleHsp" style=""></span>hours&#46; No reduction was observed in the metastases after almost a month of treatment&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">At week 4 of treatment&#44; the patient presented at the emergency department of his reference hospital with itching and reddening of the face and scalp&#46; He reported no previous symptoms or fever&#46; The physical examination revealed an exanthematous macular-papular rash on the neck&#44; trunk&#44; and extremities&#46; The patient was admitted and treated with oral corticosteroids and antibiotics&#46; Over the next 48<span class="elsevierStyleHsp" style=""></span>hours&#44; he developed dysphagia&#44; a tendency towards low blood pressure&#44; and decreased urine output&#46; A severe drug reaction was suspected and the patient was transferred to the burn unit at our hospital&#46; On arrival&#44; 72<span class="elsevierStyleHsp" style=""></span>hours after the onset of symptoms&#44; he was afebrile&#44; hemodynamically stable&#44; and breathing spontaneously&#46; Physical examination showed extensive body surface involvement &#40;85&#37;&#41; and epidermal detachment &#40;60&#37;&#41;&#44; in addition to erosions affecting the ocular&#44; oral&#44; and genital mucosa &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46; His heart rate was 95<span class="elsevierStyleHsp" style=""></span>bpm and oxygen saturation was 100&#37;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Radiologic evaluation on admission showed enlarged hila and hilar and parahilar lymph nodes&#46; There were no areas of consolidation&#46; The most relevant laboratory findings were a C-reactive protein level of 86&#44; a prothrombin ratio of 60&#46;5&#37;&#44; and an internationalized normal ratio of 1&#46;25&#46; Biopsy showed extensive confluent necrosis in the epidermis and subepidermal detachment&#46; There was a predominantly perivascular lymphoplasmacytic infiltrate in the dermis &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; The patient was diagnosed with toxic epidermal necrolysis due to vemurafenib&#44; with a score of 3 on the SCORTEN scale&#46; Vemurafenib had been withdrawn on admission&#44; and treatment initiated with intravenous ciclosporin 75<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>hours&#44; in addition to selective digestive decontamination&#44; vitamin and nutritional support&#44; and fluid therapy&#46; The necrotic areas of the skin were removed&#44; cleaned with saline solution and chlorhexidine&#44; and covered with Biobrane dressings &#40;Smith &#38; Nephew&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">During the first 48<span class="elsevierStyleHsp" style=""></span>hours of admission at our hospital&#44; the lesions progressed to affect 90&#37; of the total body surface&#46; On day 4&#44; the necrolysis stopped and the first signs of reepithelialization were seen&#46; Reepithelialization was complete 2 weeks later&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Immediate complications were femoral deep vein thrombosis&#44; followed by pulmonary embolism&#46; Delayed complications included nail loss and adhesions in both external ear canals and in the balanopreputial sulcus&#46; Finally&#44; the patient required amniotic membrane transplantation due to necrosis of the conjunctival membranes&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The patient was discharged a month later&#46; Ciclosporin was progressively tapered to zero&#44; with administration of 150<span class="elsevierStyleHsp" style=""></span>mg and 100<span class="elsevierStyleHsp" style=""></span>mg for 5 days each&#46; The patient returned to his reference hospital&#44; where treatment with ipilimumab and radiation therapy reduced the metastases&#46; He is currently stable and in good general health&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Vemurafenib is a selective inhibitor of the <span class="elsevierStyleItalic">BRAF</span> V600 mutation that was approved by the US Food and Drug Agency for the treatment of metastatic or unresectable melanoma in 2011&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> About 40&#37; to 60&#37; of melanomas are BRAF-positive&#44; and the mutation causes constitutive activation of the mitogen-activated protein kinase pathway&#44; which in turn leads to uncontrolled cell growth and increased cell proliferation and invasive capacity&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">2&#44;3</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Most mutations are V600E &#40;valine to glutamic acid substitution&#41;&#44; but there are also other less common mutations&#44; such as V600K&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">In the BRIM3 phase 3 clinical trial&#44; 675 patients were randomly allocated to treatment with either vemurafenib or dacarbazine&#46; In the vemurafenib group&#44; there was a 63&#37; reduction in the risk of death and a 74&#37; reduction in the risk of death or disease progression&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> In addition&#44; the phase 1 and 2 trials showed response rates of up to 50&#37; and an overall mean survival of between 14 and 16 months&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">5&#44;6</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Treatment with vemurafenib&#44; however&#44; is not free of adverse effects&#44; among which cutaneous toxicity is the most common&#46; The most common cutaneous effects are rash&#44; photosensitivity&#44; pruritus&#44; alopecia&#44; palmar erythrodysesthesia&#44; verrucal keratosis&#44; keratoacanthomas&#44; and squamous cell carcinomas&#46; Almost 40&#37; of patients develop a rash&#44; which generally does not require treatment to be discontinued as most cases are mild &#40;grade 1&#41; or moderate &#40;grade 2&#41;&#46; Dose reductions or treatment discontinuation are only necessary in patients with severe rash &#40;grade 3&#41; or intolerable grade 2 rash&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">7</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Severe cutaneous reactions to vemurafenib are very uncommon&#44; and just 1 case of Steven-Johnson syndrome and another of toxic epidermal necrolysis were reported in the BRIM3 study&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">However&#44; new cases of severe cutaneous toxicity have appeared since the launch of the drug&#46; Wantz et al&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a> reported one of the first cases of toxic epidermal necrolysis due to vemurafenib in Europe&#46; Treatment was discontinued and the necrolysis resolved&#44; but the patient died from melanoma some months later&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">The suspected drug should be withdrawn in all cases of toxic epidermal necrolysis and patients should be managed by specialized units&#46; Although is no scientific evidence supporting the use of systemic therapy&#44; at our hospital we use ciclosporin&#44; as it rapidly stops progression of the rash&#44; is well tolerated&#44; and does not increase the risk of infection or death&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">9</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">We have presented the first case of toxic epidermal necrolysis due to vemurafenib in Spain&#46; We believe that patients on this drug should be closely monitored by a dermatologist&#44; with careful attention paid to the development of skin rash with signs of severity&#44; such as epidermal detachment or mucosal involvement&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0075" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicts of Interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Lapresta A&#44; Dotor A&#44; Gonz&#225;lez-Herrada C&#46; Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib&#46; Actas Dermosifiliogr&#46; 2015&#59;106&#58;682&#8211;683&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1221
            "Ancho" => 1628
            "Tamanyo" => 354872
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Generalized eruption consisting of erythematous macules&#44; with a tendency to coalesce&#44; flaccid blisters&#44; and areas with erosions covered with Biobrane dressings&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1221
            "Ancho" => 1628
            "Tamanyo" => 295783
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Higher-magnification image showing large superficial blisters and areas of necrosis&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1627
            "Ancho" => 1221
            "Tamanyo" => 697919
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Histology showed extensive&#44; confluent necrosis in the epidermis and subepidermal detachment&#46; In the upper dermis&#44; there was a predominantly perivascular lymphoplasmacytic infiltrate &#40;hematoxylin-eosin&#44; original magnification &#215;2&#46;5&#41;&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:9 [
            0 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Improved survival with vemurafenib in melanoma with BRAF V600E mutation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;B&#46; Chapman"
                            1 => "A&#46; Hauschild"
                            2 => "C&#46; Robert"
                            3 => "J&#46;B&#46; Haanen"
                            4 => "P&#46; Ascierto"
                            5 => "J&#46; Larkin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1103782"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "2507"
                        "paginaFinal" => "2516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21639808"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New therapeutic targets in melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;M&#46; Mart&#237;"
                            1 => "A&#46; Sorolla"
                            2 => "A&#46; Yeramian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2011.08.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr&#46;"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "paginaInicial" => "579"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22261672"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Bollag"
                            1 => "P&#46; Hirth"
                            2 => "J&#46; Tsai"
                            3 => "J&#46; Zhang"
                            4 => "P&#46;N&#46; Ibrahim"
                            5 => "H&#46; Cho"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nature09454"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nature&#46;"
                        "fecha" => "2010"
                        "volumen" => "467"
                        "paginaInicial" => "596"
                        "paginaFinal" => "599"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20823850"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Distinguishing clinicopathologic features of patients with V600E and V600<span class="elsevierStyleHsp" style=""></span>K BRAF-mutant metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Menzies"
                            1 => "L&#46;E&#46; Haydu"
                            2 => "L&#46; Visintin"
                            3 => "M&#46;S&#46; Carlino"
                            4 => "J&#46;R&#46; Howle"
                            5 => "J&#46;F&#46; Thompson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1158/1078-0432.CCR-12-0052"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Cancer Res&#46;"
                        "fecha" => "2012"
                        "volumen" => "18"
                        "paginaInicial" => "3242"
                        "paginaFinal" => "3249"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22535154"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inhibition of mutated&#44; activated BRAF in metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;T&#46; Flaherty"
                            1 => "I&#46; Puzanov"
                            2 => "K&#46;B&#46; Kim"
                            3 => "A&#46; Ribas"
                            4 => "G&#46;A&#46; McArthur"
                            5 => "J&#46;A&#46; Sosman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2010"
                        "volumen" => "363"
                        "paginaInicial" => "808"
                        "paginaFinal" => "819"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Sosman"
                            1 => "K&#46;B&#46; Kim"
                            2 => "L&#46; Schuchter"
                            3 => "R&#46; Gonzalez"
                            4 => "A&#46;C&#46; Pavlick"
                            5 => "J&#46;S&#46; Weber"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1112302"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2012"
                        "volumen" => "366"
                        "paginaInicial" => "707"
                        "paginaFinal" => "714"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22356324"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Analysis of dermatologic events in vemurafenib-treated patients with melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;E&#46; Lacouture"
                            1 => "M&#46; Duvic"
                            2 => "A&#46; Hauschild"
                            3 => "V&#46;G&#46; Prieto"
                            4 => "C&#46; Robert"
                            5 => "D&#46; Schadendorf"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1634/theoncologist.2012-0333"
                      "Revista" => array:6 [
                        "tituloSerie" => "Oncologist&#46;"
                        "fecha" => "2013"
                        "volumen" => "18"
                        "paginaInicial" => "314"
                        "paginaFinal" => "322"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23457002"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vemurafenib-induced toxic epidermal necrolysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Wantz"
                            1 => "I&#46; Spanoudi-Kitrimi"
                            2 => "A&#46; Lasek"
                            3 => "D&#46; Lebas"
                            4 => "J&#46;F&#46; Quinchon"
                            5 => "P&#46; Modiano"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.annder.2013.10.054"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Dermatol Venereol&#46;"
                        "fecha" => "2014"
                        "volumen" => "141"
                        "paginaInicial" => "215"
                        "paginaFinal" => "218"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24635957"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Toxic epidermal necrolysis&#58; Part II prognosis&#44; sequelae&#44; diagnosis&#44; differential diagnosis&#44; prevention&#44; and treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;A&#46; Schwartz"
                            1 => "P&#46;H&#46; McDonough"
                            2 => "B&#46;W&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2013.05.002"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2013"
                        "volumen" => "69"
                        "paginaInicial" => "187"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23866879"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002127/v1_201510011018/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010600000008/v1_201510011018/S1578219015002127/v1_201510011018/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002127?idApp=UINPBA000044"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Case and Research Letters
Toxic epidermal necrolysis induced by vemurafenib
Necrólisis epidérmica tóxica por vemurafenib
A. Laprestaa,
Autor para correspondencia
amlapresta@gmail.com

Corresponding author.
, A. Dotorb, C. González-Herradaa
a Servicio de Dermatología, Hospital Universitario de Getafe, Getafe, Madrid, Spain
b Servicio de Anatomía Patológica, Hospital Universitario de Getafe, Getafe, Madrid, Spain
Leído
4950
Veces
se ha leído el artículo
1770
Total PDF
3180
Total HTML
Compartir estadísticas
 array:24 [
  "pii" => "S1578219015002127"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.07.014"
  "estado" => "S300"
  "fechaPublicacion" => "2015-10-01"
  "aid" => "1170"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2015;106:682-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 772
    "formatos" => array:3 [
      "EPUB" => 50
      "HTML" => 521
      "PDF" => 201
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731015002008"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2015.03.008"
      "estado" => "S300"
      "fechaPublicacion" => "2015-10-01"
      "aid" => "1170"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; y AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2015;106:682-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 924
        "formatos" => array:3 [
          "EPUB" => 3
          "HTML" => 503
          "PDF" => 418
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
        "titulo" => "Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "682"
            "paginaFinal" => "683"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Toxic epidermal necrolysis induced by vemurafenib"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figura 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 732
                "Ancho" => 976
                "Tamanyo" => 146372
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">En esta imagen a mayor aumento&#44; se aprecian grandes ampollas superficiales y &#225;reas de necrosis&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; Lapresta, A&#46; Dotor, C&#46; Gonz&#225;lez-Herrada"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Lapresta"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Dotor"
              ]
              2 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Gonz&#225;lez-Herrada"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015002127"
          "doi" => "10.1016/j.adengl.2015.07.014"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002127?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002008?idApp=UINPBA000044"
      "url" => "/00017310/0000010600000008/v1_201510020746/S0001731015002008/v1_201510020746/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219015002048"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.07.006"
    "estado" => "S300"
    "fechaPublicacion" => "2015-10-01"
    "aid" => "1171"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:684-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 676
      "formatos" => array:3 [
        "EPUB" => 50
        "HTML" => 390
        "PDF" => 236
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Erythema Multiforme Contact Dermatitis After Accidental Exposure to Acrylate-based Printing Inks"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "684"
          "paginaFinal" => "685"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eritema multiforme de contacto tras exposici&#243;n accidental a acrilatos en tintas de impresi&#243;n"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 472
              "Ancho" => 1300
              "Tamanyo" => 114379
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B&#44; Similar lesions on both thighs and the trunk &#40;areas not exposed to direct contact with ink&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S&#46; C&#243;rdoba, N&#46; Puente, A&#46; Calder&#243;n, J&#46;M&#46; Borbujo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "C&#243;rdoba"
            ]
            1 => array:2 [
              "nombre" => "N&#46;"
              "apellidos" => "Puente"
            ]
            2 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Calder&#243;n"
            ]
            3 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Borbujo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101500201X"
        "doi" => "10.1016/j.ad.2015.02.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101500201X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002048?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002048/v1_201510011018/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219015002103"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.07.012"
    "estado" => "S300"
    "fechaPublicacion" => "2015-10-01"
    "aid" => "1168"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:680-1"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 746
      "formatos" => array:3 [
        "EPUB" => 44
        "HTML" => 481
        "PDF" => 221
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Tuberous Lesion of the Penis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "680"
          "paginaFinal" => "681"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Lesi&#243;n tuberosa en el pene"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 732
              "Ancho" => 976
              "Tamanyo" => 268580
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Intranuclear human herpes virus 8 &#40;HVV-8&#41; expression &#40;immunohistochemical HHV-8 stain&#44; original magnification &#215;40&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Miguel-G&#243;mez, S&#46; P&#233;rez-Gala, P&#46; Ja&#233;n-Olasolo"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Miguel-G&#243;mez"
            ]
            1 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "P&#233;rez-Gala"
            ]
            2 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Ja&#233;n-Olasolo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731015001982"
        "doi" => "10.1016/j.ad.2015.02.010"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015001982?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002103?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002103/v1_201510011018/en/main.assets"
  ]
  "en" => array:16 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
    "titulo" => "Toxic epidermal necrolysis induced by vemurafenib"
    "tieneTextoCompleto" => true
    "saludo" => "To the Editor&#58;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "682"
        "paginaFinal" => "683"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Lapresta, A&#46; Dotor, C&#46; Gonz&#225;lez-Herrada"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Lapresta"
            "email" => array:1 [
              0 => "amlapresta&#64;gmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Dotor"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Gonz&#225;lez-Herrada"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario de Getafe&#44; Getafe&#44; Madrid&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Anatom&#237;a Patol&#243;gica&#44; Hospital Universitario de Getafe&#44; Getafe&#44; Madrid&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1627
            "Ancho" => 1221
            "Tamanyo" => 697919
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Histology showed extensive&#44; confluent necrosis in the epidermis and subepidermal detachment&#46; In the upper dermis&#44; there was a predominantly perivascular lymphoplasmacytic infiltrate &#40;hematoxylin-eosin&#44; original magnification &#215;2&#46;5&#41;&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We report the case of a 68-year-old man diagnosed with a nodular melanoma &#40;Breslow depth&#44; 11<span class="elsevierStyleHsp" style=""></span>mm&#41; in the right submammary region&#46; He had no relevant past history and reported taking no medication&#44; Radiography showed enlarged bilateral axillary&#44; mediastinal&#44; and hilar lymph nodes and multiple bilateral micronodules in the upper and lower lobes of the lung&#46; These nodules showed high uptake&#44; suggestive of metastatic lesions&#44; on the positron emission tomography&#8211;computed tomography scan&#46; Assessment of the <span class="elsevierStyleItalic">BRAF</span> V600E mutation was positive&#46; With a diagnosis of BRAF-positive stage IV metastatic melanoma&#44; treatment was initiated with vemurafenib 960&#160;mg every 12<span class="elsevierStyleHsp" style=""></span>hours&#46; No reduction was observed in the metastases after almost a month of treatment&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">At week 4 of treatment&#44; the patient presented at the emergency department of his reference hospital with itching and reddening of the face and scalp&#46; He reported no previous symptoms or fever&#46; The physical examination revealed an exanthematous macular-papular rash on the neck&#44; trunk&#44; and extremities&#46; The patient was admitted and treated with oral corticosteroids and antibiotics&#46; Over the next 48<span class="elsevierStyleHsp" style=""></span>hours&#44; he developed dysphagia&#44; a tendency towards low blood pressure&#44; and decreased urine output&#46; A severe drug reaction was suspected and the patient was transferred to the burn unit at our hospital&#46; On arrival&#44; 72<span class="elsevierStyleHsp" style=""></span>hours after the onset of symptoms&#44; he was afebrile&#44; hemodynamically stable&#44; and breathing spontaneously&#46; Physical examination showed extensive body surface involvement &#40;85&#37;&#41; and epidermal detachment &#40;60&#37;&#41;&#44; in addition to erosions affecting the ocular&#44; oral&#44; and genital mucosa &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46; His heart rate was 95<span class="elsevierStyleHsp" style=""></span>bpm and oxygen saturation was 100&#37;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Radiologic evaluation on admission showed enlarged hila and hilar and parahilar lymph nodes&#46; There were no areas of consolidation&#46; The most relevant laboratory findings were a C-reactive protein level of 86&#44; a prothrombin ratio of 60&#46;5&#37;&#44; and an internationalized normal ratio of 1&#46;25&#46; Biopsy showed extensive confluent necrosis in the epidermis and subepidermal detachment&#46; There was a predominantly perivascular lymphoplasmacytic infiltrate in the dermis &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; The patient was diagnosed with toxic epidermal necrolysis due to vemurafenib&#44; with a score of 3 on the SCORTEN scale&#46; Vemurafenib had been withdrawn on admission&#44; and treatment initiated with intravenous ciclosporin 75<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>hours&#44; in addition to selective digestive decontamination&#44; vitamin and nutritional support&#44; and fluid therapy&#46; The necrotic areas of the skin were removed&#44; cleaned with saline solution and chlorhexidine&#44; and covered with Biobrane dressings &#40;Smith &#38; Nephew&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">During the first 48<span class="elsevierStyleHsp" style=""></span>hours of admission at our hospital&#44; the lesions progressed to affect 90&#37; of the total body surface&#46; On day 4&#44; the necrolysis stopped and the first signs of reepithelialization were seen&#46; Reepithelialization was complete 2 weeks later&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Immediate complications were femoral deep vein thrombosis&#44; followed by pulmonary embolism&#46; Delayed complications included nail loss and adhesions in both external ear canals and in the balanopreputial sulcus&#46; Finally&#44; the patient required amniotic membrane transplantation due to necrosis of the conjunctival membranes&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The patient was discharged a month later&#46; Ciclosporin was progressively tapered to zero&#44; with administration of 150<span class="elsevierStyleHsp" style=""></span>mg and 100<span class="elsevierStyleHsp" style=""></span>mg for 5 days each&#46; The patient returned to his reference hospital&#44; where treatment with ipilimumab and radiation therapy reduced the metastases&#46; He is currently stable and in good general health&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Vemurafenib is a selective inhibitor of the <span class="elsevierStyleItalic">BRAF</span> V600 mutation that was approved by the US Food and Drug Agency for the treatment of metastatic or unresectable melanoma in 2011&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> About 40&#37; to 60&#37; of melanomas are BRAF-positive&#44; and the mutation causes constitutive activation of the mitogen-activated protein kinase pathway&#44; which in turn leads to uncontrolled cell growth and increased cell proliferation and invasive capacity&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">2&#44;3</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Most mutations are V600E &#40;valine to glutamic acid substitution&#41;&#44; but there are also other less common mutations&#44; such as V600K&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">In the BRIM3 phase 3 clinical trial&#44; 675 patients were randomly allocated to treatment with either vemurafenib or dacarbazine&#46; In the vemurafenib group&#44; there was a 63&#37; reduction in the risk of death and a 74&#37; reduction in the risk of death or disease progression&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> In addition&#44; the phase 1 and 2 trials showed response rates of up to 50&#37; and an overall mean survival of between 14 and 16 months&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">5&#44;6</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Treatment with vemurafenib&#44; however&#44; is not free of adverse effects&#44; among which cutaneous toxicity is the most common&#46; The most common cutaneous effects are rash&#44; photosensitivity&#44; pruritus&#44; alopecia&#44; palmar erythrodysesthesia&#44; verrucal keratosis&#44; keratoacanthomas&#44; and squamous cell carcinomas&#46; Almost 40&#37; of patients develop a rash&#44; which generally does not require treatment to be discontinued as most cases are mild &#40;grade 1&#41; or moderate &#40;grade 2&#41;&#46; Dose reductions or treatment discontinuation are only necessary in patients with severe rash &#40;grade 3&#41; or intolerable grade 2 rash&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">7</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Severe cutaneous reactions to vemurafenib are very uncommon&#44; and just 1 case of Steven-Johnson syndrome and another of toxic epidermal necrolysis were reported in the BRIM3 study&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">However&#44; new cases of severe cutaneous toxicity have appeared since the launch of the drug&#46; Wantz et al&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a> reported one of the first cases of toxic epidermal necrolysis due to vemurafenib in Europe&#46; Treatment was discontinued and the necrolysis resolved&#44; but the patient died from melanoma some months later&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">The suspected drug should be withdrawn in all cases of toxic epidermal necrolysis and patients should be managed by specialized units&#46; Although is no scientific evidence supporting the use of systemic therapy&#44; at our hospital we use ciclosporin&#44; as it rapidly stops progression of the rash&#44; is well tolerated&#44; and does not increase the risk of infection or death&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">9</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">We have presented the first case of toxic epidermal necrolysis due to vemurafenib in Spain&#46; We believe that patients on this drug should be closely monitored by a dermatologist&#44; with careful attention paid to the development of skin rash with signs of severity&#44; such as epidermal detachment or mucosal involvement&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0075" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicts of Interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Lapresta A&#44; Dotor A&#44; Gonz&#225;lez-Herrada C&#46; Necr&#243;lisis epid&#233;rmica t&#243;xica por vemurafenib&#46; Actas Dermosifiliogr&#46; 2015&#59;106&#58;682&#8211;683&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1221
            "Ancho" => 1628
            "Tamanyo" => 354872
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Generalized eruption consisting of erythematous macules&#44; with a tendency to coalesce&#44; flaccid blisters&#44; and areas with erosions covered with Biobrane dressings&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1221
            "Ancho" => 1628
            "Tamanyo" => 295783
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Higher-magnification image showing large superficial blisters and areas of necrosis&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1627
            "Ancho" => 1221
            "Tamanyo" => 697919
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Histology showed extensive&#44; confluent necrosis in the epidermis and subepidermal detachment&#46; In the upper dermis&#44; there was a predominantly perivascular lymphoplasmacytic infiltrate &#40;hematoxylin-eosin&#44; original magnification &#215;2&#46;5&#41;&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:9 [
            0 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Improved survival with vemurafenib in melanoma with BRAF V600E mutation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;B&#46; Chapman"
                            1 => "A&#46; Hauschild"
                            2 => "C&#46; Robert"
                            3 => "J&#46;B&#46; Haanen"
                            4 => "P&#46; Ascierto"
                            5 => "J&#46; Larkin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1103782"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "2507"
                        "paginaFinal" => "2516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21639808"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New therapeutic targets in melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;M&#46; Mart&#237;"
                            1 => "A&#46; Sorolla"
                            2 => "A&#46; Yeramian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2011.08.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr&#46;"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "paginaInicial" => "579"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22261672"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Bollag"
                            1 => "P&#46; Hirth"
                            2 => "J&#46; Tsai"
                            3 => "J&#46; Zhang"
                            4 => "P&#46;N&#46; Ibrahim"
                            5 => "H&#46; Cho"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nature09454"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nature&#46;"
                        "fecha" => "2010"
                        "volumen" => "467"
                        "paginaInicial" => "596"
                        "paginaFinal" => "599"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20823850"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Distinguishing clinicopathologic features of patients with V600E and V600<span class="elsevierStyleHsp" style=""></span>K BRAF-mutant metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Menzies"
                            1 => "L&#46;E&#46; Haydu"
                            2 => "L&#46; Visintin"
                            3 => "M&#46;S&#46; Carlino"
                            4 => "J&#46;R&#46; Howle"
                            5 => "J&#46;F&#46; Thompson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1158/1078-0432.CCR-12-0052"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Cancer Res&#46;"
                        "fecha" => "2012"
                        "volumen" => "18"
                        "paginaInicial" => "3242"
                        "paginaFinal" => "3249"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22535154"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inhibition of mutated&#44; activated BRAF in metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;T&#46; Flaherty"
                            1 => "I&#46; Puzanov"
                            2 => "K&#46;B&#46; Kim"
                            3 => "A&#46; Ribas"
                            4 => "G&#46;A&#46; McArthur"
                            5 => "J&#46;A&#46; Sosman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2010"
                        "volumen" => "363"
                        "paginaInicial" => "808"
                        "paginaFinal" => "819"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Sosman"
                            1 => "K&#46;B&#46; Kim"
                            2 => "L&#46; Schuchter"
                            3 => "R&#46; Gonzalez"
                            4 => "A&#46;C&#46; Pavlick"
                            5 => "J&#46;S&#46; Weber"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1112302"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2012"
                        "volumen" => "366"
                        "paginaInicial" => "707"
                        "paginaFinal" => "714"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22356324"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Analysis of dermatologic events in vemurafenib-treated patients with melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;E&#46; Lacouture"
                            1 => "M&#46; Duvic"
                            2 => "A&#46; Hauschild"
                            3 => "V&#46;G&#46; Prieto"
                            4 => "C&#46; Robert"
                            5 => "D&#46; Schadendorf"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1634/theoncologist.2012-0333"
                      "Revista" => array:6 [
                        "tituloSerie" => "Oncologist&#46;"
                        "fecha" => "2013"
                        "volumen" => "18"
                        "paginaInicial" => "314"
                        "paginaFinal" => "322"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23457002"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vemurafenib-induced toxic epidermal necrolysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Wantz"
                            1 => "I&#46; Spanoudi-Kitrimi"
                            2 => "A&#46; Lasek"
                            3 => "D&#46; Lebas"
                            4 => "J&#46;F&#46; Quinchon"
                            5 => "P&#46; Modiano"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.annder.2013.10.054"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Dermatol Venereol&#46;"
                        "fecha" => "2014"
                        "volumen" => "141"
                        "paginaInicial" => "215"
                        "paginaFinal" => "218"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24635957"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Toxic epidermal necrolysis&#58; Part II prognosis&#44; sequelae&#44; diagnosis&#44; differential diagnosis&#44; prevention&#44; and treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;A&#46; Schwartz"
                            1 => "P&#46;H&#46; McDonough"
                            2 => "B&#46;W&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2013.05.002"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2013"
                        "volumen" => "69"
                        "paginaInicial" => "187"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23866879"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010600000008/v1_201510011018/S1578219015002127/v1_201510011018/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010600000008/v1_201510011018/S1578219015002127/v1_201510011018/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015002127?idApp=UINPBA000044"
]
Información del artículo
ISSN: 15782190
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 11 4 15
2024 Octubre 89 40 129
2024 Septiembre 84 21 105
2024 Agosto 107 57 164
2024 Julio 80 31 111
2024 Junio 102 29 131
2024 Mayo 60 29 89
2024 Abril 78 24 102
2024 Marzo 73 30 103
2024 Febrero 53 40 93
2024 Enero 58 28 86
2023 Diciembre 70 19 89
2023 Noviembre 75 26 101
2023 Octubre 84 28 112
2023 Septiembre 79 39 118
2023 Agosto 52 22 74
2023 Julio 54 29 83
2023 Junio 53 21 74
2023 Mayo 72 24 96
2023 Abril 64 20 84
2023 Marzo 55 27 82
2023 Febrero 39 21 60
2023 Enero 39 29 68
2022 Diciembre 45 44 89
2022 Noviembre 37 24 61
2022 Octubre 24 24 48
2022 Septiembre 25 39 64
2022 Agosto 26 36 62
2022 Julio 26 37 63
2022 Junio 35 25 60
2022 Mayo 34 39 73
2022 Abril 47 36 83
2022 Marzo 36 50 86
2022 Febrero 23 29 52
2022 Enero 25 38 63
2021 Diciembre 37 39 76
2021 Noviembre 45 40 85
2021 Octubre 32 49 81
2021 Septiembre 24 31 55
2021 Agosto 25 16 41
2021 Julio 22 25 47
2021 Junio 15 20 35
2021 Mayo 31 19 50
2021 Abril 63 56 119
2021 Marzo 54 23 77
2021 Febrero 65 25 90
2021 Enero 30 15 45
2020 Diciembre 24 12 36
2020 Noviembre 27 21 48
2020 Octubre 29 5 34
2020 Septiembre 43 17 60
2020 Agosto 21 21 42
2020 Julio 31 16 47
2020 Junio 34 30 64
2020 Mayo 28 8 36
2020 Abril 33 11 44
2020 Marzo 29 11 40
2020 Febrero 3 0 3
2020 Enero 4 4 8
2019 Diciembre 8 0 8
2019 Noviembre 4 1 5
2019 Septiembre 8 1 9
2019 Agosto 4 0 4
2019 Julio 2 0 2
2019 Junio 6 1 7
2019 Mayo 2 8 10
2019 Abril 0 1 1
2019 Marzo 2 3 5
2019 Enero 6 0 6
2018 Diciembre 11 0 11
2018 Noviembre 3 0 3
2018 Octubre 4 0 4
2018 Septiembre 8 0 8
2018 Marzo 1 0 1
2018 Febrero 81 4 85
2018 Enero 29 5 34
2017 Diciembre 67 10 77
2017 Noviembre 18 2 20
2017 Octubre 20 8 28
2017 Septiembre 13 7 20
2017 Agosto 23 6 29
2017 Julio 17 9 26
2017 Junio 18 10 28
2017 Mayo 18 6 24
2017 Abril 22 7 29
2017 Marzo 21 10 31
2017 Febrero 14 9 23
2017 Enero 14 6 20
2016 Diciembre 15 21 36
2016 Noviembre 28 25 53
2016 Octubre 20 28 48
2016 Agosto 1 1 2
2016 Julio 1 2 3
2016 Junio 4 0 4
2016 Mayo 1 0 1
2016 Abril 3 0 3
2016 Febrero 0 4 4
2015 Noviembre 0 2 2
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?